White Papers

FDA Fronts Pivotal Life Sciences Trend in 2020

Issue link: https://read.uberflip.com/i/1214067

Contents of this Issue

Navigation

Page 0 of 7

Trend Brief FDA Fronts Pivotal Life Sciences Trend in 2020 The life sciences industry is experiencing a surge of scientific and technology advances. However, there remains a sizeable gap between the innovations and the technologies in order to translate them into useful therapies. The U.S. Food and Drug Administration (FDA) is endeavoring to close that gap with an initiative to foster modernization in the life sciences industry — beginning with its own technology infrastructure. In 2019, the agency introduced its Technology Modernization Action Plan (TMAP), a program designed to bring the organization up to speed with the latest technologies in order to expedite breakthrough discoveries with the intent of improving public health. 1 This publication provides an in-depth look at the FDA's transformation and addresses how the agency's initiative will impact manufacturers of regulated products.

Articles in this issue

view archives of White Papers - FDA Fronts Pivotal Life Sciences Trend in 2020